NCT04007601 - Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) | Biotech Hunter

Enrollment

127

Participants

Timeline

Start Date

December 12, 2019

Primary Completion Date

June 21, 2023

Study Completion Date

June 21, 2023

Conditions

Acute Lymphoblastic Leukemia

Interventions

DEVICE

Active tDCS

Participants will receive active 1mA direct current stimulation over the left dorsolateral prefrontal cortex for 20 minutes. Cognitive training: Participants will complete 20 minutes of online cognitive training via Lumosity two days per week for a 6-month intervention period.

DEVICE

Sham tDCS

Participants will receive sham (no direct current) stimulation over the left dorsolateral prefrontal cortex for 20 minutes. Cognitive training: Participants will complete 20 minutes of online cognitive training via Lumosity two days per week for a 6-month intervention period.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

St. Jude Children's Research Hospital

OTHER